glp-1 influencers Does injection site location matter as much as the say?, #obesitymedicine #womenshealth #obesitydoctor Glucagon-Like Peptide 1 (GLP-1) Receptor

Patients should be aware that insurance coverage for compounded formulations or off-label dosing approaches is often limited, potentially creating additional financial barriers to care

SGLT-2 Inhibitors: The Gap Seems to Be Leveling Off

Biologia (Bratisl), 73:563-568

In a recent industry roundtable published in FoodBev magazine, Annabel Twinberrow, analyst at Agriculture and Horticulture Development Board (AHDB), noted the expectation that uptake of the medications in the UK will increase as oral options become available only 14% of people surveyed by IGD in January 2026 said they would try injections, she pointed out